PubMed · 15630438
Immune complexes as therapy for autoimmunity.
Abstract
For several decades, intravenous Ig has been used as treatment for a variety of immune-related diseases, including immune thrombocytopenic purpura (ITP), autoimmune neuropathies, systemic lupus erythematosus, myasthenia gravis, Guillain-Barré syndrome, skin blistering syndromes, and Kawasaki disease. Despite years of use, its mechanism of immunomodulation is still unclear. Recent studies using mouse models of ITP and arthritis, including one reported in this issue of the JCI, now provide some insights into this mechanism and the rationale for the development of Fcgamma receptor-targeted therapeutics.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Raphael Clynes. 2005. Immune complexes as therapy for autoimmunity.. https://doi.org/10.1172/jci23994
Cite the original work for its findings. Save a collection to share your selection of sources.